Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Efficacy of Combined Antithrombotic Treatment with Strong Antiplatelet Agents in Patients with Atrial Fibrillation and Acute Coronary Syndrome: A Randomized Controlled Study

  • By

  • Konstantinos D. Rizas

  • Konstantinos Mourouzis

  • Dominik Rath

  • Christoph B. Olivier

  • Laura Elisa Villegas Sierra

  • Theofanis Korovesis

  • Amin Polzin

  • Amani Al Tawil

  • Reza Wakili

  • Lukas von Stuelpnagel

  • Katharina Mayer

  • Marion Janisch

  • Tanja Ulrich

  • Sarah Lang

  • Sebastian K. G. Maier

  • Florian Brattinger

  • Lorenz Bott-Flügel

  • Harilaos Bogossian

  • Konstantinos Iliodromitis

  • Luisa Freyer

  • Julius Steffen

  • Konstantin Stark

  • Elodie Eiffener

  • Lauren E. Sams

  • Tobias Petzold

  • Axel Linke

  • Felix M. Heidrich

  • Samuel Sossala

  • Saif Zako

  • Nikolaos Dagkonakis

  • Andreas Schäfer

  • Frank Edelmann

  • David M. Leistner

  • Mariya Maslarska

  • Fabian Knebel

  • Georg Nickenig

  • Blerim Luani

  • Tienush Rassaf

  • Hüseyin Ince

  • Ibrahim Akin

  • Micha T. Maeder

  • Meinrad Gawaz

  • Hans-Josef Feistritzer

  • Norbert Frey

  • Stefan Kääb

  • Riza Sahin

  • Matthias Pauschinger

  • Thomas Stiermaier

  • Ingo Eitel

  • Marc Kollum

  • Jan Sebastian Wolter

  • Michael Schreinlechner

  • Axel Bauer

  • Christoph Stellbrink

  • Ulf Landmesser

  • Paulus Kirchhof

  • Dirk Sibbing

  • Holger Thiele

  • Adnan Kastrati

  • Ulrich Mansmann

  • Steffen Massberg

  • August 29, 2026

Share

Original Source(s)

Related Content